Trials / Completed
CompletedNCT03908697
Quantum Natural Family Planning Pilot
Comparison of Two Hormonal Fertility Monitors for Use in Natural Family Planning
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Quanovate Tech Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
•The Pilot study will involve current Marquette Method users who own and use a ClearBlue Fertility monitor and who will be asked to simultaneously use the Mira monitor for the sake of comparing the two devices to monitor the menstrual cycle.
Detailed description
* The Mira fertility monitoring system (www.miracare.com) is a new home-use hormone tracking device with the ability to quantitatively measure reproductive hormones in the urine but is also synced to a smart phone App that provides a graphic representation of the hormonal levels throughout a menstrual cycle. * The Mira monitor will be compared to the ClearBlue Fertility Monitor for its ease of use, satisfaction, and accuracy. * The Mira hormonal monitor and App system has not been tested for its use in Natural Family Planning (NFP). * The Pilot study will involve current Marquette Method users who own and use a ClearBlue Fertility monitor and who will be asked to simultaneously use the Mira monitor for the sake of comparing the two devices. * Female participants invited to participate will need to meet the following criteria: * Age 18 to 42 years * Menstrual cycle ranging between 21-42 days * At least 3 cycles after cessation of breastfeeding * Not currently on medications that affect ovulation and 3 months prior * Not currently pregnant or breastfeeding * No known fertility problems * Not planning on achieving pregnancy during the 3 menstrual cycles of the study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mira monitor comparison to ClearBlue monitor | Testing first morning urine with hormone test sticks at home |
Timeline
- Start date
- 2020-05-29
- Primary completion
- 2021-02-28
- Completion
- 2021-04-22
- First posted
- 2019-04-09
- Last updated
- 2025-03-24
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03908697. Inclusion in this directory is not an endorsement.